| Product Name | MF | CAS | Details |
|---|
| HIF-2α-IN-9 | C12H13F5O4S2 | 2648334-36-3 | Details |
| NNRTIs-IN-1 | C28H22N6O3 | 2925364-09-4 | Details |
| HIV-1 protease-IN-8 | C25H35N3O5S | 2925287-55-2 | Details |
| Antimalarial agent 26 | C20H22N4O3 | 2299199-56-5 | Details |
| ATR-IN-23 | C20H22N6O3S2 | 2923800-62-6 | Details |
| TNF-α-IN-10 | C17H14O4 | 2247720-56-3 | Details |
| AMPA receptor modulator-4 | C11H12ClFN2O2S | 2917551-59-6 | Details |
| MDM2/XIAP-IN-2 | C29H32N2O4S | 2761969-85-9 | Details |
| SLMP53-2 | C26H22N2O2 | 1826116-38-4 | Details |
| Lp-PLA2-IN-12 | 2637485-14-2 | Details |
| Antimalarial agent 24 | C20H16N4O2 | 2299199-54-3 | Details |
| Antileishmanial agent-16 | C27H37N5O4 | 2934738-41-5 | Details |
| Enpp-1-IN-17 | C18H24N4O2 | 2289736-54-3 | Details |
| Antileishmanial agent-15 | C28H39N5O4 | 2934738-38-0 | Details |
| A1/A3 AR antagonist 3 | C22H19N5O3 | 2665804-57-7 | Details |
| HIV-1 inhibitor-56 | C22H14ClN7O2S | 2952530-45-7 | Details |
| ALK2-IN-5 | C24H32N8O2 | 2414149-20-3 | Details |
| Antibacterial agent 141 | C23H27ClN2O3 | 2930013-56-0 | Details |
| HDAC ligand-1 | C7H8N2O | 34840-28-3 | Details |
| PB131 | C16H16FN3O2 | 2924425-63-6 | Details |
| TRK-IN-23 | C20H17FN4O2 | 2924344-29-4 | Details |
| Antileishmanial agent-17 | C27H37N5O5 | 2934738-40-4 | Details |
| Mcl-1 inhibitor 13 | 2445466-06-6 | Details |
| RIP1 kinase inhibitor 4 | 2919836-00-1 | Details |
| RIP1 kinase inhibitor 6 | C19H18F2N2O3 | 2428401-62-9 | Details |
| RIP1 kinase inhibitor 5 | C13H17F2NO2 | 2428422-17-5 | Details |
| Tau protein aggregation-IN-1 | C17H11BrN2O2 | 916179-45-8 | Details |
| Bromodomain inhibitor-12 | 2010124-06-6 | Details |
| TLR7/8 agonist 8 | C24H30N6O | 2649170-16-9 | Details |
| CXCR4-IN-1 | C23H32N6 | 2304750-48-7 | Details |
| Tegeprotafib | C13H11FN2O5S | 2407610-46-0 | Details |
| TLR7/8 agonist 9 | C20H26N6O | 2649170-17-0 | Details |
| PCSK9-IN-17 | C16H19N5OS | 2455424-72-1 | Details |
| IRE1α kinase-IN-9 | C24H24N2O6 | 1338933-30-4 | Details |
| Lp-PLA2-IN-15 | C22H17F5N4O3 | 1865796-11-7 | Details |
| Bivamelagon | C35H53ClN4O4 | 2641595-54-0 | Details |
| ATR-IN-24 | C23H26N6O2 | 2370889-43-1 | Details |
| Lp-PLA2-IN-13 | C22H17F5N4O4 | 2756855-62-4 | Details |
| Bromodomain inhibitor-12 (edisylate) | C28H38N4O5.C2H6O6S2 | 2010124-27-1 | Details |
| Antifungal agent 59 | 2422019-96-1 | Details |
| Bivamelagon hydrochloride | C35H54Cl2N4O4 | 2641595-55-1 | Details |
| MEK-IN-6 hydrate | 2845153-35-5 | Details |
| THRβ receptor agonist-1 | 2403721-00-4 | Details |
| HPK1 antagonist-1 | C28H29FN6O2 | 2628489-56-3 | Details |
| RIP1 kinase inhibitor 7 | C20H20FN3O | 2428401-23-2 | Details |
| MEK-IN-6 | C18H20FN3O4S | 2845151-86-0 | Details |
| IRE1α kinase-IN-8 | 1338933-29-1 | Details |
| VMAT2-IN-2 tosylate | C27H36F3NO6S | 2608770-12-1 | Details |
| PCSK9-IN-16 | C16H20N6O2S3 | 2455424-51-6 | Details |
| Lp-PLA2-IN-16 | C22H17F5N4O3 | 1865780-73-9 | Details |
| Lp-PLA2-IN-14 | 2756855-66-8 | Details |
| ROCK-IN-6 | C19H19N5O8S | 2489328-74-5 | Details |
| SORT-PGRN interaction inhibitor 3 | C15H19Cl2NO3 | 2691846-87-2 | Details |
| RET-IN-23 | C28H28FN11 | 2479961-46-9 | Details |
| IPG7236 | C23H31N3O3S | 2756350-91-9 | Details |
| SHP2-IN-14 | C22H20Cl2N8O | 2673400-91-2 | Details |
| P2X3 antagonist 38 | C22H25F3N6O3 | 2545974-71-6 | Details |
| Mosnodenvir | C26H22ClF3N2O6S | 2890688-86-3 | Details |
| TLR8 agonist 6 | C19H29N7O2 | 2616605-55-9 | Details |
| KAT modulator-1 | C20H36O2 | 1314006-43-3 | Details |
| JAK-IN-28 | C20H18ClN7O | 2445500-22-9 | Details |
| DGKζ-IN-1 | C27H25F3N6O2S | 2660218-70-0 | Details |
| Protein kinase inhibitor 5 | C29H31F2N7O | 2278204-94-5 | Details |
| PI3Kγ inhibitor 7 | C31H25N9O2 | 2575863-25-9 | Details |
| SOS1/KRAS-IN-1 | C24H26F3N5O | 2836330-34-6 | Details |
| K-80001 | C20H17FO2 | 242800-40-4 | Details |
| SOS1-IN-16 | C30H31F3N4O3 | 2930763-85-0 | Details |
| CDK7-IN-22 | C22H25F3N6 | 2173190-60-6 | Details |
| URAT1&XO inhibitor 2 | C14H12BrNO3 | 1239488-96-0 | Details |
| URAT1&XO inhibitor 1 | C20H13N5O3S | 2669726-78-5 | Details |
| DRI-C21041 | C30H21N3O7S | 2101765-78-8 | Details |
| STAT6-IN-3 | C32H35IN3O7P | 371919-80-1 | Details |
| FKBP51F67V-selective antagonist Ligand2 | C43H56N2O10 | 1680228-76-5 | Details |
| SUCNR1-IN-1 | C26H22ClF3N2O4 | 2711753-52-3 | Details |
| PROTAC α-synuclein degrader 5 | C39H41N7O10 | 2781922-42-5 | Details |
| AMPK activator 11 | C25H20N4O2 | 2948304-00-3 | Details |
| JAK-IN-30 | C19H26N8S | 2891469-99-9 | Details |
| ETAP | C18H17N3O | 2575731-47-2 | Details |
| PHD2-IN-1 | C21H23ClN4O5 | 2768219-28-7 | Details |
| PIKfyve-IN-2 | C22H22N8O | 2245319-25-7 | Details |
| Antiproliferative agent-32 | C19H15NO2 | 2925814-05-5 | Details |
| BChE-IN-17 | C23H23BrN2O4S2 | 2425632-57-9 | Details |
| Tubulin polymerization-IN-42 | C22H21NO5 | 2640220-51-3 | Details |
| MmpL3-IN-2 | C27H30N2 | 2944458-65-3 | Details |
| SARS-CoV-2-IN-57 | C23H37N3O | 1265624-68-7 | Details |
| BBDDL2059 | C27H36N4O4S | 2691174-27-1 | Details |
| BDM91514 | 2892824-90-5 | Details |
| MAT2A-IN-12 | C20H17NO3 | 631897-75-1 | Details |
| FGFR-IN-11 | C28H29ClN4O4 | 2658488-68-5 | Details |
| Antitumor agent-101 | C26H38N6O3 | 2848632-52-8 | Details |
| DSO-5a | C23H24N2O7 | 2195411-63-1 | Details |
| Z1078601926 | C14H19FN2O | 1493256-85-1 | Details |
| SSI-4 | C19H21ClN4O3 | 1875084-68-6 | Details |
| UPCDC30766 | C30H32F2N6O3S | 2152623-68-0 | Details |
| DRI-C25441 | C31H21N3O6 | 2101765-83-5 | Details |
| Antiproliferative agent-30 | C24H26N4O4 | 2713553-88-7 | Details |
| IRAK4-IN-28 | C27H31N9O3 | 2952532-92-0 | Details |
| PAD4-IN-2 | C20H23BClN7O6 | 2642327-52-2 | Details |
| S-Gem | C13H15F2N3O6S2 | 2169925-98-6 | Details |
| Product Total： Product Page： | ||||
| 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 | ||||